Charles Schwab Investment Management Inc Nkarta, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 161,776 shares of NKTX stock, worth $336,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161,776

Previous 147,551 9.64%

Holding current value

$336,494

Previous $271,000 1.11%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.51 - $2.22 $21,479 - $31,579	14,225 Added 9.64%	161,776 $268,000
Q1 2025 Sep 15, 2025	SELL	$1.37 - $2.53 $19,488 - $35,989	-14,225 Reduced 8.79%	147,551 $271,000
Q1 2025 May 09, 2025	BUY	$1.37 - $2.53 $30,877 - $57,021	22,538 Added 18.03%	147,551 $271,000
Q4 2024 Feb 06, 2025	SELL	$2.17 - $4.34 $44,092 - $88,184	-20,319 Reduced 13.98%	125,013 $311,000
Q2 2024 Aug 12, 2024	BUY	$5.27 - $10.82 $294,614 - $604,881	55,904 Added 62.51%	145,332 $858,000
Q1 2024 May 08, 2024	BUY	$5.59 - $15.71 $113,583 - $319,211	20,319 Added 29.4%	89,428 $966,000
Q3 2023 Nov 08, 2023	SELL	$1.39 - $2.29 $241,481 - $397,837	-173,728 Reduced 71.54%	69,109 $96,000
Q2 2023 Aug 09, 2023	BUY	$2.19 - $5.17 $5,490 - $12,961	2,507 Added 1.04%	242,837 $531,000
Q1 2023 May 11, 2023	SELL	$3.37 - $6.3 $41,700 - $77,956	-12,374 Reduced 4.9%	240,330 $853,000
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $23,746 - $66,297	4,620 Added 1.86%	252,704 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $471,487 - $706,654	38,426 Added 18.33%	248,084 $3.27 Million
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $891,661 - $2.23 Million	114,757 Added 120.92%	209,658 $2.58 Million
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $54,445 - $94,242	-6,287 Reduced 6.21%	94,901 $1.08 Million
Q4 2021 Feb 11, 2022	BUY	$12.79 - $26.88 $39,840 - $83,731	3,115 Added 3.18%	101,188 $1.55 Million
Q3 2021 Nov 16, 2021	SELL	$26.67 - $38.76 $254,485 - $369,847	-9,542 Reduced 8.87%	98,073 $2.73 Million
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $274,879 - $421,159	-11,482 Reduced 9.64%	107,615 $3.41 Million
Q1 2021 May 17, 2021	BUY	$31.33 - $59.61 $360,451 - $685,813	11,505 Added 10.69%	119,097 $3.92 Million
Q4 2020 Feb 16, 2021	BUY	$27.03 - $75.62 $36,544 - $102,238	1,352 Added 1.27%	107,592 $6.61 Million
Q3 2020 Nov 13, 2020	BUY	$23.52 - $47.9 $2.5 Million - $5.09 Million	106,240 New	106,240 $3.19 Million

Others Institutions Holding NKTX

# of Institutions

114

Shares Held

59.1M

Call Options Held

Put Options Held

67.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $101M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Nkarta, Inc. Transaction History